Keith R. Leonard
At a glance: Keith R. Leonard is Director at Arcutis Biotherapeutics (ARQT). Their latest SEC Form 4, filed Mar 4, 2026, reported a sale of $997K. On file: 0 purchase lines ($0) and 1 sale line ($997K).
Disclosed holdings: about $589K of ARQT stock: 22,123 shares reported on their latest Form 4 (filed Mar 4, 2026), valued at the Nov 20, 2026 close of $26.64. This counts only ARQT shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Director at Arcutis Biotherapeutics, Inc. (ARQT)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Mar 4SEC | ARQTArcutis Biotherapeutics, Inc. | Sell Plan | 39,27222,123 held (−64%) | $25.39 | $997K | +4.9% |
- Sell
Director Keith R Leonard sold $997K of ARQT at $25.39 — cuts the stake by 64%; pre-scheduled 10b5-1 plan sale.
Follow Keith R. Leonard
Get one email when Keith R. Leonard files a new purchase or sale. Free.
At most one email a day about Keith R. Leonard, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.